- Advertisement -
- Advertisement -
- Advertisement -

Find a job

Subscribe for free

All things Pharma


Graham McIntosh joins UniversalProcon

Graham McIntosh has been appointed as Managing Director of the UniversalProcon Group, replacing Mike Ford who is moving on to new ventures.

Graham has been a board member of UniversalProcon since its acquisition by United Drug in 2008. Since then he has worked closely with Mike, leading the group’s recent restructure and transition to United Drug’s Contract Sales & Marketing Services Division (CSMS) in the UK and the USA.

Mike Ford said: “I’m delighted that Graham has been appointed as my successor. Having worked closely with him on the Board over the last year, I have seen the vast amount of energy, drive and commitment he has brought to the business and I am sure that UniversalProcon will go from strength to strength under his leadership.

“Graham’s first-class knowledge of the healthcare sector, combined with his passion for the healthcare meetings and events industry, will provide the expertise needed to successfully realise the company’s future growth and expansion.”

In 1998 Graham moved to the healthcare service sector as a Director of Ashfield In2Focus, the UK’s largest contract services organisation and the founder company of United Drug’s CSMS Division. He then went on to lead Ashfield In2Focus’s expansion into the USA and in 2008 was appointed as interim CEO of Ashfield Health, based at the CSMS head office in Ivyland, Pennsylvania.

On his new appointment, Graham said: “The company has an excellent international reputation and really exceptional staff that are all totally committed to delivering to customers. Mike has been key to its success and, following the acquisition last year, leaves the business with an extraordinary financial performance of a turnover of over £42m and pre-tax operating profit of £2.17m.

“By working closely with other companies in our CSMS Division and combining resources, we will enhance our ability to provide integrated solutions and deliver an unrivalled service, from which all our existing and new customers can benefit.”

Mike will remain in an advisory role for the next six months, helping to ensure a smooth transition.

- Advertisement -


- Advertisement -



Sign up to receive our digital newsletter, for all the essential headlines, Jobs of the Week and thought-provoking features.

Claim my free subscription